Form 4: CVS Health Corp: Executive Prem S. Shah Reports Stock Transactions
SEC Form 4 Filing
EVP and Group President Prem S. Shah reports acquisition and disposal of CVS Health Corp stock and stock options.
Summary
- On April 1, 2025, Prem S. Shah, EVP and Group President of CVS Health Corp, reported transactions involving the company's stock.
- Shah surrendered 1,308 shares of common stock to cover withholding taxes due upon the vesting and settlement of restricted stock units at a price of $67.98.
- Shah also acquired 26,478 restricted stock units at a price of $67.98, which vest in four equal annual installments starting April 1, 2026.
- Additionally, Shah acquired 112,289 stock options with an exercise price of $67.98, which become exercisable in four equal annual installments starting April 1, 2026, and expire on April 1, 2035.
- Following these transactions, Shah beneficially owns 47,250.677 shares of common stock directly, 58,166 restricted stock units, and 112,289 stock options.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by an executive, which is neutral in sentiment.
Positives
- The acquisition of restricted stock units and stock options indicates confidence in the company's future performance.
Future Outlook
The vesting schedule of the restricted stock units and the exercisability of the stock options provide a long-term incentive for the executive.
Industry Context
Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities, allowing investors to monitor the actions of company executives.
Comparison to Industry Standards
- Executive compensation packages including stock options and restricted stock units are common practice among publicly traded companies like CVS Health Corp to align management's interests with those of shareholders.
- Companies such as Walgreens Boots Alliance (WBA) and UnitedHealth Group (UNH) also utilize similar equity-based compensation strategies for their executives.
- The vesting schedules and exercise prices are generally structured to incentivize long-term value creation, which is a standard benchmark in the industry.
Stakeholder Impact
- Shareholders can monitor insider transactions to gain insights into management's perspective on the company's stock.
Key Dates
| Date | Description |
|---|---|
| 04/01/2025 | Date of stock transactions and grant of stock options and restricted stock units. |
| 04/01/2026 | Commencement date for vesting of restricted stock units and exercisability of stock options. |
| 04/01/2035 | Expiration date of the stock options. |
| 04/03/2025 | Date of Form 4 signature. |
Keywords
CVS Health Corp, Prem S. Shah, Stock Options, Restricted Stock Units, Form 4, Executive Compensation, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.